Novavax enters lease assignment and asset sales with AstraZeneca for $59.8M; expects Q3 non-cash charges of $125-127M

NOVAVAX INC

Assignment fee $15M, parcel sale $20M, asset sale $24.8M; total $59.8M from AstraZeneca.
Non-cash impairment of $96-98M in Q3 2025 from these transactions, plus $29M from convertible note extinguishment.
Parcel sale closes Q4 2025; lease assignment and asset sale close Q1 2026.
Novavax pays base rent for Jan-Jun 2026 under lease assignment; AstraZeneca responsible thereafter.
Corporate headquarters relocated from 700 Quince Orchard Rd to 21 Firstfield Rd, Gaithersburg.

item 1.01item 2.06item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.